StonvexLoading…
StonvexCore line items from DOO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | C$8.44B | C$7.90B | C$9.96B | C$10.03B |
Operating Income | C$399.40M | C$554.30M | C$1.41B | C$1.37B |
Net Income | C$289.30M | C$-213.00M | C$744.50M | C$865.40M |
EPS (Diluted) | C$3.95 | C$-2.86 | C$9.47 | C$10.67 |
Total Assets | C$6.32B | C$6.29B | C$6.78B | C$6.46B |
Total Liabilities | C$5.71B | C$6.05B | C$5.96B | C$5.92B |
Cash & Equivalents | C$427.10M | C$180.70M | C$491.80M | C$202.30M |
Free Cash Flow OCF − CapEx | C$914.80M | C$291.60M | C$1.11B | C$48.50M |
Shares Outstanding | 73.12M | 73.03M | 74.96M | 78.91M |